Found 3 articles for: "Nivolumab"
Case Series of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis With Nivolumab and Nivolumab/ Ipilimumab Combination Therapy in Metastatic Melanoma
May 2022 | Volume 21 | Issue 5 | Case Reports | 529 | Copyright © May 2022
Nivolumab (anti PD-1 antibody) and ipilimumab (anti CTLA-4 antibody) are immune checkpoint inhibitors (ICI) that effectively stimulate the native T cell response and lead to an antitumor response. The...
Read MoreDelayed Metastatic Polypoid Nodular Melanoma Diagnosis During COVID-19 Pandemic, Successful Treatment With Surgery and Nivolumab
December 2021 | Volume 20 | Issue 12 | Case Reports | 1343 | Copyright © December 2021
Patients with polypoid (pedunculated) melanoma have the poorest 5-year survival rate compared with all other variants of nodular melanoma, presenting with increased thickness, incidence of metastasis,...
Read MoreNivolumab Induced Psoriasis Successfully Treated With Acitretin
August 2021 | Volume 20 | Issue 8 | Editorials | 911 | Copyright © August 2021
Immunotherapy is emerging as a promising alternative treatment for a variety of solid tumors. Its beneficial effects are mediated through hijacking the immune system to mount an anti-tumor response. O...
Read More
